Harmful Misfolded Proteins Decline with Age in Alzheimer's Disease (1 of 1) (IMAGE)
Caption
The scientists' new cellular assays could assess the presence of prion-like amyloid beta (top row), alpha-synuclein (middle row), or tau proteins (bottom row) in human kidney cells, as indicated by the bright orange spots. This material relates to a paper that appeared in the May 1, 2019, issue of Science Translational Medicine, published by AAAS. The paper, by A. Aoyagi at University of California, San Francisco in San Francisco, CA; and colleagues was titled, "Aβ and tau prion-like activities decline with longevity in the Alzheimer's disease human brain."
Credit
A. Aoyagi <i>et al., Science Translational Medicine</i> (2019)
Usage Restrictions
Please cite the owner of the material when publishing. This material may be freely used by reporters as part of news coverage, with proper attribution. Non-reporters must contact <i>Science</i> for permission.
License
Licensed content